Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin 2020; 30(05): 257-270
DOI: 10.1055/a-1161-4504
CME-Fortbildung

Rehabilitation bei Herzinsuffizienz

Rehabilitation in Heart Failure
R.K. Reibis
,
A. Schlitt
,
E.H. Langheim
,
M. Guha
,
M. Halle
,
A. Boscheri
,
C. Hegeler-Molkewehrum
,
H. Völler

Die Herzinsuffizienz führt jährlich in Deutschland zu Behandlungskosten in Höhe von >5 Mrd. Euro. Die weltweite Prävalenz soll in den nächsten 15 Jahren um 25% zunehmen, und es ist mit einem Anstieg der Krankheitskosten um über 200% zu rechnen. Gründe sind u.a. die Zunahme kostenintensiver Prozeduren und die Abnahme der Krankenhausmortalität. Durch das multimodale Programm der Rehabilitation kann dieser Kreislauf unterbrochen werden.

Abstract

Heart failure patients (HF-rEF, HF-pEF or in combination) represent a relevant proportion of patients in cardiological rehabilitation facilities. They require a multimodal therapy concept due to the impaired systolic and/or diastolic ventricular function, the risk of malignant arrhythmias and the cardiac implantable electrical devices (CIED). In addition to guideline-based pharmacotherapy, individualized training therapy and psychosocial support play a key role in the rehabilitation of heart failure patients. Professional reintegration is determined by hemodynamic stability, cognitive performance, job requirements and job security, especially for CIED carriers. The suitability for driving is mainly determined in individual decisions and depends, among other things, on the left ventricular ejection fraction, the hemodynamic stability and the arrhythmia-free interval.



Publication History

Article published online:
14 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Gesundheitsberichterstattung des Bundes, Stand 03 2020. Im Internet: http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=3&p_aid=13056387&nummer=63&p_sprache=D&p_indsp=55116&p_aid=23629357 Zugriff: 23.07.2020
  • 2 Neumann T, Biermann J, Erbel R. et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106: 269-275
  • 3 Bakal JA, McAlister FA, Liu W. et al. Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations. PLoS One 2014; 9: e106494
  • 4 Corra U., Giannuzzi P, Adamopoulos S. et al. Executive summary of the Position Paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology (ESC): core components of cardiac rehabilitation in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12: 321-325
  • 5 Forman DE, Sanderson BK, Josephson RA. et al. Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities. J Am Coll Cardiol 2015; 65: 2652-2659
  • 6 Taylor RS, Walker S, Ciani O. et al. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis. Health Technol Assess 2019; 2: 1-98
  • 7 Scalvini S, Grossetti F, Paganoni A. et al. Impact of in-hospital cardiac rehabilitation on mortality and readmissions in heart failure: A population study in Lombardy, Italy, from 2005 to 2012. Eur J Prev Cardiol 2019; 26: 808-817
  • 8 S3. -Leitlinie Kardiologische Rehabilitation im deutschsprachigen Raum Europas (D-A-CH). AWMF-Registernummer 133-001
  • 9 Golwala H, Pandey A, Ju C. et al. Temporal trends and factors associated with cardiac rehabilitation referral among patients hospitalized with heart failure: Findings from Get With the Guidelines – Heart Failure Registry. J Am Coll Cardiol 2015; 66: 917-926
  • 10 Schlitt A, Wischmann P, Wienke A. et al. Rehabilitation in patients with coronary heart disease – participation and its effect on prognosis. Dtsch Arztebl Int 2015; 112: 527-534
  • 11 Klempfner R, Tzur B, Sabbag A. et al. Participation in an Exercise-Based Cardiac Rehabilitation Program and Functional Improvement of Heart Failure Patients with Preserved Versus Reduced Left Ventricular Systolic Function. Isr Med Assoc J 2018; 20: 358-362
  • 12 Deutsche Rentenversicherung Bund. Sozialmedizinische Begutachtung für die gesetzliche Rentenversicherung 7. Aufl Berlin, Heidelberg: Springer; 2011: 311-312
  • 13 Galderisi M, Cosyns B, Edvardsen T. et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2017; 18: 1301-1310
  • 14 Čelutkienė J, Plymen CM, Flachskampf FA. et al. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018; 20: 1615-1633
  • 15 Görg W, Schwerk WB.. Die Real-Time Sonographie in der Diagnostik von Pleuraergüssen. In Gebhardt J. Ultraschalldiagnostik '89. Berlin: Springer; 1990: 385-387
  • 16 Corrà U, Piepoli MF, Adamopoulos S. Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC. Eur J Heart Fail 2014; 16: 929-941
  • 17 Guazzi M, Myers J, Peberdy MA. et al. Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction. Cardiopulm Rehabil Prev 2010; 30: 165-172
  • 18 Kinoshita H, Sairaku A, Morishima N. et al. Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing. Int J Cardiol 2020; 301: 142-146
  • 19 Bittner V, Weiner DH, Yusuf S. et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993; 270: 1702-1707
  • 20 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891-975
  • 21 Dahal K, Chapagain B, Maharjan R. et al. Prolonged Cardiac Monitoring to Detect Atrial Fibrillation after Cryptogenic Stroke or Transient Ischemic Attack: A Meta-Analysis of Randomized Controlled Trials. Ann Noninvasive Electrocardiol 2016; 21: 382-388
  • 22 Cowie MR, Woehrle H, Wegscheider K. et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 2015; 373: 1095-1105
  • 23 Ambrosy AP, Butler J, Ahmed A. et al. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions. J Am Coll Cardiol 2014; 63: 1823-1832
  • 24 McMurray JJ, Packer M, Desai AS. et al. PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993-1004
  • 25 Solomon SD, McMurray JJV, Anand IS. et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2019; 381: 1609-1620
  • 26 Bonsu KO, Arunmanakul P, Chaiyakunapruk N.. Pharmacological treatments for heart failure with preserved ejection fraction – a systematic review and indirect comparison. Heart Fail Rev 2018; 23: 147-156
  • 27 Vanhees L, Geladas N, Hansen D. et al. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR. Part II. Eur J Prev Cardiol 2012; 19: 1005-1033
  • 28 Piepoli MF, Corra U, Agostoni PG. et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 150-164
  • 29 Wolpern AE, Burgos DJ, Janot JM, Dalleck LC. Is a threshold-based model a superior method to the relative percent concept for establishing individual exercise intensity? A randomized controlled trial. BMC Sports Sci Med Rehabil 2015; 7: 16
  • 30 Karvonen J, Vuorimaa T. Heart rate and exercise intensity during sports activities. Practical application. Sports Med 1988; 5: 303-311
  • 31 Scherr J, Wolfarth B, Christle JW. et al. Associations between Borg's rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol 2013; 113: 147-155
  • 32 Schwarz S, Halle M. Exercise training in heart failure patients. Dtsch Med Wochenschr 2014; 139: 845-850
  • 33 Ellingsen Ø, Halle M, Conraads V. et al. High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction. Circulation 2017; 135: 839-849
  • 34 Van der Wal MH, Jaarsma T, Moser DK. et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2006; 27: 434-444
  • 35 Dougherty CM, Glenny RW, Burr RL. et al. Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator. Circulation 2015; 131: 1835-1842
  • 36 Heidbüchel H, Corrado D, Biffi A. et al. Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and RehabilitationRecommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 2006; 13: 676-686
  • 37 Volkmann H. Störbeeinflussung von implantierten Herzschrittmachern im medizinischen Bereich. Herzschr Elektrophys 2004; 15: 65-72
  • 38 Krabatsch T, Potapov E, Soltani S. et al. Ventrikuläre Langzeitunterstützung mit implantierbaren kontinuierlichen Flusspumpen. Herz 2015; 40: 231-329
  • 39 German Society for Thoracic and Cardiovascular Surgery: GSTCVS Annual Registry. Survey Period 2014. Im Internet: https://idw-online.de/de/attachmentdata43088.pdf; Stand: 14.06.2020
  • 40 Feldman D, Pamboukian SV, Teuteberg JJ. et al. ISHLT Guidelines for Mechanical Circulatory Support. J Heart Lung Transplant 2013; 32: 157-187
  • 41 Reiss N, Schmidt T, Langheim E. et al. Inpatient Cardiac Rehabilitation of LVAD Patients-Updated Recommendations from the Working Group of the German Society for Prevention and Rehabilitation of Cardiovascular Diseases. Thorac Cardiovasc Surg 2019; DOI: 10.1055/s-0039-1691837.
  • 42 Christle JW, Boscheri A, Pressler A. et al. Interval exercise training increases maximal and submaximal exercise performance in heart failure with biventricular assist device therapy. Int J Cardiol 2015; 187: 104-105
  • 43 Kalbfleisch KR, Lehmann MH, Steinman RT. Reemployment following implantation of the automatic cardioverter defibrillator. Am J Cardiol 1989; 64: 199-202
  • 44 Christensen AV, Øhlers AA, Zwisler AD, Svendsen JH, Berg SK. Employment Status and Sick Leave After First-Time Implantable Cardioverter Defibrillator Implantation: Results From the COPE-ICD Trial. J Cardiovasc Nurs 2017; 32: 448-454
  • 45 Götz M. EMF-Warngerät für Herzschrittmacher- und ICD-Patienten. Arbeitsschutz aktuell 2005; 10: 426-430
  • 46 Bundesministerium für Verkehr, Bau und Stadtentwicklung. 2010. Fahrerlaubnis-Verordnung vom 13. Dezember 2010 (BGBl. I S. 1980), zuletzt durch Artikel 1 der Verordnung vom 7. Januar 2011(BGBl. I S. 3) geändert. Im Internet: http://bundesrecht.juris.de/bundesrecht/fev_2010/gesamt.pdf. Stand: 14.06.2020
  • 47 Lewrenz H, Jagow FJ, Eggersmann A. et al. Bundesanstalt für Straßenwesen: Begutachtungsleitlinien zur Kraftfahrereignung. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit. Heft M 115. Bremerhaven: Wirtschaftsverlag NW, Verlag für neue Wissenschaft GmbH; 2000
  • 48 Im Internet: whttps://bast.opus.hbz-nrw.de/files/2330/M115-2019.pdf Stand: 14.06.2020
  • 49 Im Internet: https://leitlinien.dgk.org/2018/pocket-leitlinie-fahreignung-bei-kardiovaskulaeren-erkrankungen-version-2018/ Stand: 14.06.2020
  • 50 van den Hurk K, Reijmer YD, van den Berg E. et al. Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail 2011; 13: 1362-1369
  • 51 Hjelm C, Broström A, Dahl A. et al. Factors associated with increased risk for dementia in individuals age 80 years or older with congestive heart failure. J Cardiovasc Nurs 2014; 29: 82-90
  • 52 Laederach-Hofmann K, Buri C, Bunzel B. et al. Lebensqualität bei Patienten mit Herzinsuffizienz und Evaluation zur Herztransplantation: Eine Übersicht. J Kardiol 2010; 17: 14-24
  • 53 Broström A, Strömberg A, Dahlström U. et al. Congestive heart failure, spouses and the couple’s sleep situation: a critical incident technique analysis. J Clin Nurs 2003; 12: 223-233
  • 54 Alosco ML, Spitznagel MB, Cohen R. et al. Cardiac rehabilitation is associated with lasting improvements in cognitive function in older adults with heart failure. Acta Cardiol 2014; 69: 407-414
  • 55 Mandras SA, Uber PA, Mehra MR. Sexual activity and chronic heart failure. Mayo Clin Proc 2007; 82: 1203-1210
  • 56 Giagulli VA, Moghetti P, Kaufman JM. et al. Managing erectile dysfunction in heart failure. Endocr Metab Immune Disord Drug Targets 2013; 13: 125-134
  • 57 Steinke EE. How can heart failure patients and their partners be counseled on sexual activity?. Curr Heart Fail Rep 2013; 10: 262-269